pure tirzepatide compound Tirzepatide| CAS 2023788-19-2 - Order from Adipogen Life Sciences Compounded Tirzepatide (GLP-1/GIP)

Ongoing Support and Follow-Up We're not a "one and done" kind of practice

Tirzepatide availability Tirzepatide has been FDA-approved and available since 2022 for type 2 diabetes (as Mounjaro) and since 2023 for weight management (as Zepbound)

Weight loss is non-linear

Storage and handling considerations Compounded tirzepatide requires proper refrigeration to maintain potency and stability

The same principle applies to dosing for Mounjaro, a weekly injection that works by making you feel fuller for longer, and reducing food noise and cravings

This dual action is why tirzepatide generally produces greater weight loss and HbA1c reduction compared to GLP-1-only medications